U.S. approves Alzheimer’s drug that modestly slows disease

WASHINGTON (AP) — U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.

Read more…

Please follow and like us: